Cancer jasmine

Levi F, Soussan A, Adam R, Caussanel JP, Metzger G, Jasmin C, Bismuth H, Smolensky M, Misset JL. A phase I-II trial of five-day continuous intravenous infusion of 5-fluorouracil delivered at circadian rhythm modulated rate in patients with metastatic colorectal cancer. J Infus Chemother 1995 5(3 Suppl l) 153-8. 

Negrier MS, Pourreau CN, Palmer PA, Ranchere JY, Mercatello A, Viens P, Blaise D, Jasmin C, Misset JL, Franks CR, et al. Phase I trial of recombinant interleukin-2 followed by recombinant tumor necrosis factor in patients with metastatic cancer. J Immunother 1992 11(2) 93-102. 

Levi, F.A., R. Zidani, J.-M. Vannetzel, B. Perpoint, C. Focan, R. Faggiulo, P. Chollet, C. Garufi, M. Itzhaki, L. Dogliotti, S. lacobelli, R. Adam, F. Kunstlinger, J. Gastiaburu, H. Bismuth, C. Jasmin J.L. Misset. 1994. Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases a randomized multi-institutional trial. J. Natl Cancer Inst. 86 1608-17. 

Blanchet-Bardon C, Nazzaro V, Rognin C, Geiger J-M, Puissant A (1991) Acitretin in the treatment of severe disorders of keratinization. Results of an open study. J Am Acad Dermatol 24 982-986 Bollag W, Holdener EE (1992) Retinoids in cancer prevention and therapy. Ann Oncol 3 513-526 Bonhonune L, Fredj G, Ecstein E, Maurisson G, Farabas C, Misset JL, Jasmin C (1994) Treatment of AIDS-associated Kaposi s sarcoma with oral tretinoin. Am J Hosp Pharm 51 2417-2419. 

---